Annual Scientific Meeting – Liverpool 2024


Dear Colleagues

It is with great pleasure that we welcome you in Liverpool for the 10th – 12th July 2024 Annual Scientific Meeting of the British Gynaecological Cancer Society (BGCS).

The focus of the meeting is going to be on “Paradigm shift in Management of Gynaecological Cancers”. The past decade has seen rapid changes with new evidence informing our practice, so let us present the latest emerging evidence to map our path to improving patient care. The proposed scientific programme will reflect the interests of all stakeholders and disciplines who share a common goal in improving gynaecological cancer care.The meeting will take place at ACC (Arena and Convention Centre) situated on our wonderful waterfront. The conference centre has won the best UK conference centre award 7 times, an ideal venue to host our meeting.

We very much hope that you enjoy what will be a lively and informative meeting and we hope you will find plenty of opportunities to network with old and new colleagues at the social events. Liverpool is an amazing city, one of the most visited destinations in the UK, offering a fantastic cultural experience. Enjoy your visit to the city and immerse yourself in the beauty of its iconic waterfront and attractions.

Welcome to Liverpool!

With best wishes,

Mohamed Mehasseb
Chair of the Local Organising Committee

  • Liverpool Gynaecological Oncology Cadaveric Surgery Course

    Venue: Human Anatomy Resource Centre (HARC), The Anatomy  Department, University of Liverpool, Sherrington Building, Ashton Street, Liverpool, L69 3GE

    A one day advanced cadaveric surgery course  and workshop aimed at Consultants Gynaecological Oncologists, Clinical Fellows and Senior Trainees who have an interest in Gynaecological Oncology.


    • Reinforcing surgical anatomy knowledge
    • Engagement into multi disciplinary complex surgery
    • Training into advanced surgical techniques used for oncological surgery
    • Managing of potential complications
    • Gain insight into available surgical instruments and energy sources


    Experienced Gynaecological Oncologists, Colorectal and Urology Surgeons involved in the complex pelvic and peritoneal oncological services in Liverpool Women’s Hospital and the Royal Liverpool University.

    Number strictly limited to 10 dissecting candidates (2 per cadaver). Non-dissecting observing candidates are welcome (maximum 5).

    Please book early to secure your place.

    Course Directors
    Mr Mohamed Mehasseb and Mr Mohamed Otify, Consultants Gynaecological Surgeons & Oncologists, Liverpool Women’s Hospital

    Fees and Registration
    The registration fees for dissecting candidates is £900, and for non dissecting observing candidates is £450.

    The fees include admission to the lectures, course pack and material, coffee and lunch. The course dinner is provided free of charge, courtesy of our Sponsors, Ethicon Endosurgery.

    For application and to secure a place, please contact:

  • Clinical Nurses Specialists Forum

    Time: 13:30 – 16:30
    Venue: Liverpool Women’s Hospital – Blair Bell Education Centre

    The BGCS Nursing Sub-Group is delighted to be hosting an extended agenda the BGCS Annual Scientific Meeting 2024 in Liverpool.  We have listened to your feedback, and we recognise the importance of your voice and supporting you.

    There will be not just one, but 2 nursing sessions in BGCS 2024 in Liverpool!  As normal, we will have our pre-planned slot on the Thursday 11th July 2024 morning, as we do each year with some new and exciting topics. But additionally, we are hosting a more informal afternoon on the Wednesday afternoon, where we will have the opportunity to connect, spend time together and chew the cud! We are so excited to give you this extra opportunity.

    The theme is going to be “It’s all about You” and it will be a good opportunity to exchange ideas and experiences. The venue will be the Blair Bell Education Centre in the Liverpool Women’s Hospital. Knowing many of you will travel the day before in any event, it seemed like too good an opportunity to miss.  We do hope you will join us at this event too, that will run free of charge, courtesy of the Local Organising Committee. A huge thank you to our Liverpool hosts.

    13:30-14:00     Registration

    14:00-14:15     Welcome

    14:15-14:30     Meet your Neighbour – Speed Dating

    14:30-15:00     Complex Cases Review

    15:00-15:15     Refreshments

    15:15-15:45     Developing Resilience

    15:45-16:15     Where do we go from here?

    16:15-16:30     Event close

    Please put the date in your calendars – one not to miss!

    Hilary Maxwell – Chair of the BGCS Nursing Forum
    Mohamed Mehasseb – Chair of the Local Organising Committee

  • British Surgical Gynaecological Oncology Group (BSGOG) 2024 Annual Conference

    Time: 08:45 – 18:30
    Venue: Spaces at the Spine, The Spine Building, 2 Paddington Village, Liverpool L7 3FA


    The primary objectives of the BSGOG are to focus on surgical procedures, surgical techniques, surgical training/education, surgical innovations, including surgical equipment, and novel technologies in addition to developing and promoting surgical trials.

    This one day meeting will include a series of live surgical procedures, surgical videos, informal presentations, interactive debates, audience discussions and equipment/technology demonstrations.

    There will be real-time 2-way audio visual link-up to live surgeries,  including advanced bowel resections and upper abdominal surgeries in advanced ovarian cancer.

    Please note, the live surgical cases will be finalised a few days before the session, depending on availability and suitability.

    08:00    Delegate registration

    08:45    Welcome & Introductions – Raj Naik, Christophe Pomel, Roberto Tozzi, Georgios Androutsopoulos, Mohamed Mehasseb

    09:00    Surgical Video 1: Bowel Resections in Advanced Ovarian Cancer

    09:30    Surgical Video 2: PlasmaJet Resection/Ablation in Ovarian Cancer & PlaComOv Trial – Simon Butler-Manuel

    10:00    Surgical Video 3: Robotic Rad Hyst & Vaginal Cuff Prep: RAC Trial Update – Henrik Falconer

    10:30    Surgical Video 4: Laparoscopic Rad Hyst & Vaginal Cuff Preparation – Denis Querleu & Cherif Akladios

    11:00    Surgical Video 5: ICG for Bowel Anastomoses – David Jayne

    11:30    Discussion 1: Update on SHAPE Trial – Marie Plante

    12:00    Discussion 2: Update on ROCC Trial and Trials in Stage I Cervical Disease – Nadeem Abu-Rustrum

    12:30    Discussion 3: Update on TRUST Trial – Christina Fotopoulou

    13:00    Lunch Break

    14:00    Sponsored Sessions

          •   Stryker, ICG Technology Update
          •   PlasmaSurgical Technology Update
          •   Intuitive Surgical, Robotic Technology Update
          •   IGEA Medical, Electro-Chemotherapy Technology Update


    15:00    Discussion 4: Update on ROCKETS Trial – Sudha Sundar

    15:30    Discussion 5: Update on MIRRORS Trial – Christina Uwins

    15:45    Discussion 6: Robotic Simulation & Training the Trainers – Tom Ind

    16:00    Discussion 7: Mastery Study – Marielle Nobbenhuis

    16:15    Discussion 8: HIPEC Trials – Des Barton & Owen Heath

    16:30    Discussion 9: ICG and vulva cancer studies – John Butler

    16:45    Discussion 10: Ano-colic anastomoses: Side to End or End to End? – Ioannis Kotsopoulos

    17:00    Discussion 11: EndoCare Trial – Emma Crosbie

    17:15    Discussion 12: Tailored Endometrial Surgery by Molecular Profiling – Mara Kyrgiou

    17:30    Discussion 13: KolGo TRG GCIG Surgical Studies from India – Asima Mukhopadhyay

    17:45    Discussion 14: Mental Health in SOCQER2 Patients – Aati Lakhiani

    18:00    Discussion 15: HGSOC & 2 week wait referrals – Audrey Kwong

    18:15    Discussion 16: CERVANTES Trial Update

    The event will be followed by an informal educational/networking event at a local restaurant (limited spaces available, delegates are required to pre-book at the point of registration).


    Endorsed by ESGO


09:00-09:10 Welcome and Introductions
09:10-10:40 Plenary Session 1: Endometrial Cancer Parallel Session: Nurses Session
09:10-09:30 Innovation in endometrial cancer diagnostics The role of research nurses in gynaecological cancer
09:30-09:50 Molecular classification endometrial cancer / MMR testing Patient Supported Follow Up (PSFU)
09:50-10:10 FIGO 2023 staging for endometrial cancer: an update Onco-psychology support for women with gynaecological cancers and their partners
10:10-10:40 Recurrent endometrial cancer: to operate or not? Sexual dysfunction in women with gynaecological cancer
10:40-11:00 Refreshment Break, Exhibition & Posters
11:00-12:30 Plenary Session 2: Complex and Multidisciplinary Surgery Parallel Session: Clinical oncology
11:00-11:30 Multivisceral resection: The Liverpool Experience Immunotherapy for Endometrial Cancer
11:30-12:00 Prehabilitation & Enhanced Recovery for ultraradical ovarian surgery Practice-changing non-surgical treatment of cervical cancer
12:00-12:30 Exenteration in modern gynaecological oncology setup Complex gynae brachytherapy
12:30-13:30 Lunch, Exhibition & Posters
13:30-15:00 Plenary Session 3: Vulval cancer Parallel Session: Unit Leads session
13:30-14:00 The prevention and management of treatment related morbidity in vulval cancer
13:30-13:50 Two-week wait referrals and Rapid Access Clinic: a new approach to an old problem?
13:50-14:10 ORADS on ultrasound scan and MRI: characterising ovarian lesions
14:00-14:30 Precancerous lesions of the vulva: an update
14:10-14:30 Screening for high-risk genetic patients and the PROTECTOR Study
14:30-15:00 Plastic reconstructive techniques in vulval cancer surgery
14:30-14:50 Non-surgical management of endometrial cancer/atypical hyperplasia
14:50-15:00 Discussion on role of BGCS for Unit Leads
15:00-15:30 Refreshment Break, Exhibition & Posters
15:30-17:00 Plenary Session 2: Ovarian Cancer
15:30-16:00 Standardizing ovarian cancer surgery and peri-operative care
16:00-16:30 Recurrent ovarian cancer: to operate or not to operate?
16:30-16:45 HIPEC in ovarian cancer – is it time to implement it?
16:45-17:00 The National Ovarian Cancer Audit - first report
17:00-17:30 AGM (BGCS Members only)
19:30-23:30 Conference Dinner - Liverpool Town Hall

FRIDAY 12th JULY 2024

09:00-09:10 Welcome and Introductions
09:10-10:40 Plenary Session 5: Gynaecological cancers from childhood to menopause Parallel Session: Radiology session
09:10-09:40 Paediatric tumours
09:10-09:30 Gynaecological MRI: Current limitations and future innovations
09:30-10:00 AI and predictive scoring for ovarian cancer
09:40-10:10 Fertility options for women with gynaecological cancers
10:00-10:20 Correlation between radiological and surgical PCI – Are we getting it right?
10:10-10:40 Menopause: how to support women with gynaecological cancers
10:20-10:40 The role of PETCT in gynaecological cancer
10:40-11:00 Refreshment Break, Exhibition & Posters
11:00-12:30 Plenary Session 6: Oral presentations Parallel Session: Medical Oncology
11:00-11:20 Systemic Maintenance therapy in ovarian cancer – an update
11:20-11:40 Management of Neuroendocrine tumours and Genital tract Sarcomas
11:40-12:00 Novel approaches to managing gestational trophoblastic tumours in the age of immunotherapy
12:00-12:30 New therapies for low grade and clear cell ovarian cancers
12:30-13:30 Lunch, Exhibition & Posters
13:30-15:00 Plenary Session 7: Screening and Prevention Parallel Session: Palliative care and dietetics
13:30-14:00 Cancer genetics and Lynch screening Principles of Palliative care in gynaecological cancers
14:00-14:30 Ovarian cancer screening: have we given up?
14:00-14:20 Nutrition issues in gynaecological cancers
14:20-14:40 The role of the modern CNS in delivering palliative and end of life care
14:30-15:00 HPV vaccination and effect on gynaecological cancers
14:40-15:00 Frailty scores – how to decide on fitness to treat
15:00-15:15 Refreshment Break, Exhibition & Posters
15:15-16:45 Plenary Session 8: Cervical Cancer
15:15-15:45 SHAPE Trial – an update and peri-operative care
15:45-16:15 De-escalation of surgery in cervical cancer
16:15-16:45 Minimal Access Surgery for cervical cancer is dead – a debate
16:45-17:00 Closing Session & Prizes/Awards


Thursday 11th July

Emma Crosbie

Prof Emma Crosbie

Professor of Gynaecological Oncology, University of Manchester


Presentation Title
Innovation in endometrial cancer diagnostics

Speaker Bio
Prof Crosbie is an NIHR Advanced Fellow, Professor and Honorary Consultant Gynaecological Oncologist at the University of Manchester. Her research focuses on screening, prevention and early diagnosis of gynaecological cancers. Her team showed which patients with endometrial cancer should be tested for Lynch syndrome, how they should be tested, that women want to be tested to protect their family members and that testing everyone is cost-effective for the NHS. This led directly to a change in NICE guidance that all women with endometrial cancer be offered testing for Lynch syndrome.

She is Chair of the RCOG Academic Board, Deputy Editor-in-Chief for BJOG, Chair of the Research Advisory Board for The Eve Appeal and member of the RCOG Blair Bell Research Society, roles that enable her to pursue her keen interest in nurturing the next generation of clinical academics.

Gregory Cross

Dr Gregory Cross

Consultant Histopathologist, Royal Liverpool University Hospital


Presentation Title
Molecular classification endometrial cancer / MMR testing

Speaker Bio
Dr Cross is a consultant histopathologist specialising in gynaecological pathology. He trained as a pathologist in Merseyside and has been lead gynaecological pathologist at Liverpool University Hospitals NHS Foundation Trust since 2022.

Christina Fotopoulou

Prof Christina Fotopoulou

Professor of Gynaecological Oncology Surgery, Imperial College London


Presentation Title
FIGO 2023 staging for endometrial cancer: an update

Speaker Bio
Christina is the Deputy Director of the Ovarian Cancer Action Research Centre at Imperial College. She holds a honorary chair in the Gynaecology Department at the Charite’ University of Berlin, where she was trained and then later took the role of the Vice Director of the Gynecological Department.

Her surgical and scientific expertise focusses on the management of patients with advanced and relapsed ovarian cancer, profiling of tumor heterogeneity and integration of tumorbiology factors with surgical effort under the umbrella of individualisation of surgical care.

She has served as the Chair of the guidelines committees of the British Gynaecological Cancer Society (BGCS) and of ESGO (European Society of Gynaecologic Oncology) and has been an elected member of the ESGO Council. She is also a member of the German AGO Ovarian Cancer Group.

She is on the editorial board and reviewer of numerous international gynaecological and oncological journals and is member of various international oncological committees, including BGCS, ASCO, ESGO, IGCS, ESMO, ENGOT, AGO, SGO and NOGGO.

Raj Naik

Mr Raj Naik

Consultant Gynaecological Oncologist, Northern Gynaecological Oncology Centre


Presentation Title
Recurrent endometrial cancer: to operate or not?

Speaker Bio
Raj is a Consultant Gynaecological Oncologist and Executive Director of the BSGOG. Former positions include BGCS President, Scientific Editor BJOG, Editorial Board Gynecologic Oncology, Cochrane Gynae Cancer Review Group Editor, RCOG Subspec Committee, NCRI Committee, EORTC QI Surgical Chair, ESGO Guidelines Committee, IGCS Education Committee, NICE Advisor, and Clinical Director of the Northern Gynaecological Oncology Centre.

With over 150 publications/reviews/chapters/editorials, including co-author of the 10th and 11th edition of Bonney’s Gynaecological Surgery, his current research and clinical interests are ultra-radical surgery for advanced ovarian cancer, exenterative surgery for recurrent disease, and sentinel node assessment for early stage gynaecological cancers.


Thursday 11th July

Sally Bell

Miss Sally Bell

Research Nurse, Liverpool Women's Hospital


Presentation Title
The role of research nurses in gynaecological cancer

Speaker Bio
Having experience clinically as a gynaecology ward/OPD nurse, Sally joined the research department in 2020 as part of the gynaecological oncology team. Her role involves identifying, educating, recruiting and supporting patients throughout the delivery of clinical trials; and liaising with the wider team to ensure they are conducted according to protocol standards.

Her current trials include developing an innovative diagnostic test for ovarian cancer and comparing simple vs radical hysterectomy in early stage cervical cancer.

Emily Rice

Mrs Emily Rice

Clinical Research Practitioner, Liverpool Women's Hospital


Presentation Title
The role of research nurses in gynaecological cancer

Speaker Bio
Emily supports the delivery of a wide variety of research studies across the NIHR Reproductive Health and Oncology portfolios, and currently leads on the delivery of several gynaecological oncology studies.

Jane Hutton

Dr Jane Hutton

Consultant Clinical Psychologist and Professional Lead for Psychology, Royal Liverpool University Hospital


Presentation Title
Onco-psychology support for women with gynaecological cancers and their partners

Speaker Bio
Jane’s team provides psychological formulation and intervention for patients living with cancer, and training and supervision for clinical nurse specialists and psychologists in training.

She was born and brought up in Liverpool and returned home in 2019, having trained at King’s College London and practised for twenty years at King’s College Hospital.

Leila Frodsham

Dr Leila Frodsham

Consultant Gynaecologist, Guy's and St Thomas's Hospital


Presentation Title
Sexual dysfunction in women with gynaecological cancers

Speaker Bio
Leila is a Consultant Gynaecologist who leads The Psychosexual Service at Guy’s and St Thomas’ NHS Foundation Trust. She also works as a foundation training programme director and Schwartz Round medical co lead. She is a Honorary Senior Lecturer at King’s College London and leads Transition to F1 and Women’s Health Block Co Lead.

She is a BMS accredited Menopause Specialist and co Founder of the Doctor’s Menopause Cafe-an educational and pastoral care space for female doctors with 6000 members.


Thursday 11th July

Nadeem Abu-Rustum

Prof Nadeem Abu-Rustum

Professor of Gynaecological Oncology, Memorial Sloan Kettering Cancer Center


Presentation Title
Exenteration in modern gynaecological oncology setup

Speaker Bio
Nadeem serves as Professor of Obstetrics and Gynaecology at Weill Cornell Medical College.

He received his medical degree from the American University of Beirut in Lebanon. He completed his residency in obstetrics and gynaecology at the Greater Baltimore Medical Center in Maryland and a fellowship in gynaecologic oncology at Memorial Sloan Kettering Cancer Center in New York.

Dr Abu-Rustum’s clinical research focuses on innovative surgical approaches, including sentinel node mapping, improved localization and visualization of tumors, fertility-sparing surgery, and laparoscopy. He also has numerous contributions to the field of gynaecologic cancer surgery for which, in 2017, he received the Society of Gynecologic Oncology SGO Innovation Award for his work on sentinel node mapping of uterine cancer. In his current role at Memorial Sloan Kettering Cancer Center, he is actively involved in the development and improvement of surgical techniques and oversees surgical research programs.

Over the years he built collaborations with numerous gynecologic oncology teams worldwide and in 2019 he was awarded the AGO Austria Wertheim award, and in 2021 the IGCS Excellence in Teaching Award.

Dr Abu-Rustum is Chair of the NCCN Cervical/Uterine/Vulva/GTD Cancers Panels and has served as a member of the Gynecologic Oncology Group Cervix Committee and the American College of Surgeons Committee on Emerging Surgical Technology and Education. He has authored or co-authored more than 450 publications and is co-author to numerous book chapters and three textbooks in gynecologic oncology. He has worked at Memorial Sloan Kettering Cancer Center for more than 25 years and is in full-time practice of gynecologic oncology in New York.


Thursday 11th July

Jonathan Ledermann

Prof Jonathan Ledermann

Professor of Medical Oncology, University College London


Presentation Title
Immunotherapy for Endometrial Cancer

Speaker Bio
Jonathan has worked at UCL Hospitals, London, UK for more than 30 years. For 22 years, he was the Director of the Cancer Research UK & UCL Cancer Trials Centre.

He specialises in the treatment of gynaecological cancers and has led several national and international trials in ovarian cancer.

He is a Fellow of the Academy of Medical Sciences and subject Editor for ESMO (European Society of Medical Oncology) Gynaecological Cancer Practice Guidelines. He was previously Vice President of ESGO (European Society of Gynaecological Oncology), chair of the NCRI UK Gynaecological Cancer Trials Group and chair of the Rare Tumour Group of the Gynaecological Cancer Intergroup.

He serves on Editorial Boards of several scientific journals and has published widely in the areas of clinical trials in gynaecological cancers, experimental therapeutics, guidelines, and education in gynaecological malignancies.

Mary McCormack

Dr Mary McCormack

Honorary Consultant Clinical Oncologist, University College London Hospitals NHS Foundation Trust


Presentation Title
Practice-changing non-surgical treatment of cervical cancer

Speaker Bio
Mary was a Consultant Clinical Oncologist at University College Hospital London until she retired from the NHS one year ago. She currently holds an honorary contract there and continues to practice in the private setting at The Harley Street Clinic.

Her major academic interest has revolved around improving outcomes in cervical cancer. She is a past chair of the GCIG Cervical Cancer Research Network. She is the CI for the INTERLACE trial and recently presented the findings at ESMO Madrid October 2023.

Hoda Al-Booz

Dr Hoda Al-Booz

Consultant Clinical Oncologist, Bristol Cancer Institute - University Hospital of Bristol


Presentation Title
Complex gynae brachytherapy

Speaker Bio

  • Gynae Clinical Oncology Consultant
  • Gynae Brachytherapy Lead
  • Morbidity and Mortality Lead
  • BGCS Clinical Oncology Council Representative


Thursday 11th July

Beth Hankinson

Dr Beth Hankinson

Consultant Radiologist, Liverpool University Hospitals NHS Foundation Trust


Presentation Title
ORADS on ultrasound scan and MRI: characterising ovarian lesions

Speaker Bio
Beth completed her undergraduate and radiology training in Liverpool. She then undertook a Fellowship in Body Imaging in Toronto, returning to Liverpool as a Consultant Radiologist at Liverpool University Hospitals NHS Foundation Trust.

Beth’s subspecialty interests are in Gynae, GI and Infections Diseases. She also has an interest in teaching and has organised several regional study days.


Wendy Macnab

Wendy Macnab

Consultant Gynaecologist, Ipswich General Hospital


Presentation Title
Non-surgical management of endometrial cancer/atypical hyperplasia

Speaker Bio
Following undergraduate training in St Andrews and Manchester, and a build your own SHO training programme across four Deaneries, Wendy undertook Obstetrics and Gynaecology Specialist Training in the East of England.

Following Sub-Specialty training in Glasgow and Norwich, Wendy settled back in the east of England and for the last five years, has been a Gynaecological Oncologist working with Stour Gynaecological Oncology centre based at Ipswich Hospital. If this doesn’t keep her busy enough, she is also Colposcopy Lead, and has previously been Governance Lead for Gynaecology.

She has recently taken on a Trust wide role as Clinical Director for Gynaecology, with a remit to maintain high standards in Gynaecology Oncology, embed GIRFT and support the expansion of robotic surgery across the specialty.


Amy Keightley

Ms Amy Keightley

Consultant Gynaecologist, Great Western Hospital


Presentation Title
Discussion on role of BGCS for Unit Leads

Speaker Bio
Amy has been a consultant in Obstetrics and Gynaecology at the Great Western Hospital Swindon since 2016 where she leads the Gynae Oncology service. She has a particular interest in laparoscopic and robotic surgery.

She is currently the Unit Lead representative for the British Gynaecological Cancer Society. She achieved a distinction in her Masters in Medical Education and continues to have an active role in medical education.


Thursday 11th July

Christophe Pomel

Prof Christophe Pomel

Professor of Gynaecological Oncology, Jean Perrin Cancer Centre


Presentation Title
Recurrent ovarian cancer: to operate or not to operate?

Speaker Bio
Christophe Pomel received his medical degree in 1993. He was invited Professor in the University of Montreal (Canada) in the Gynaecology Oncology department of Notre Dame Hospital in 1993 and 1994. He did is fellowship in the Surgical Oncology department of Jean Perrin Cancer Centre in Clermont-Ferrand (1994-1997). He worked at the Gustave Roussy Institute, Villejuif (France) from 2001 to 2005 and in the department of Gynecology Oncology, Saint Bartholomew Hospital, London (UK) from 2006 to 2008. He joined Jean Perrin cancer Centre in 2008.

Professor in Oncology and General Surgery since 2011, he is chairing the department of Surgical Oncology in Jean Perrin Cancer Centre since October 2010.

Medical Director since January 2012.

Claire Thompson

Claire Thompson

Consultant Gynaecological Oncologist, The Mater Hospital


Presentation Title
HIPEC in ovarian cancer – is it time to implement it?

Speaker Bio
Claire graduated from Queen’s University Belfast School of Medicine in 2008 and progressed to obstetrics and gynaecology training in Northern Ireland. In 2015, she commenced RCOG Subspecialty Training in gynaecological oncology at St James’s Hospital, Dublin. On completion of this three-year fellowship program, she was appointed as consultant gynaecological oncologist in Glasgow Royal Infirmary, before returning home to Ireland in 2020 to her current position in the Mater Hospital.

Her interest in medical education led to the development of surgical skills courses and she continues to be involved with training within the RCSI, RCPI and the RCOG.

Other roles include that of clinical lecturer at the RCSI and UCD. Her main surgical interests are cytoreductive surgery for advanced ovarian cancer and vulval cancer.

Sudha Sundar

Sudha Sundar

Professor of Gynaecological Cancer, Institute of Cancer and Genomic Sciences, University of Birmingham


Presentation Title
The National Ovarian Cancer Audit – first report

Speaker Bio
Sudha is a gynaecological cancer surgeon and a clinical academic. Her research programme focusses on improving ovarian cancer diagnostics, cancer surgery and addressing inequalities in cancer outcomes.

Sudha’s research has led to change of NICE guidance to recommend maximum cytoreduction surgery for ovarian cancer.



Friday 12th July

Cara Williams

Dr Cara Williams

Consultant Paediatric Gynaecologist, Liverpool Women's Hospital


Presentation Title
Paediatric tumours

Speaker Bio
Dr Williams was appointed as a Consultant at Liverpool Women’s Hospital and Alder Hey Children’s Hospital in 2016.

Dr Williams qualified in Medicine at the University of Edinburgh in 2003. She completed her specialty training in Mersey and London, during which time she completed two clinical fellowships in Paediatric and Adolescent Gynaecology at University College London Hospital and Alder Hey.

Dr Williams is the Clinical Lead for Paediatric Gynaecology at Alder Hey Children’s Hospital. She has also completed the BMS Advanced Certificate in the Principles and Practice of Menopause Care and is registered as a BMS Menopause Specialist.

Dr Williams has a special interest in Differences in sex development, Mullerian duct anomalies and Premature Ovarian Insufficiency.


Katerina Bambang

Dr Katerina Bambang

Consultant Reproductive Medicine, Liverpool Women's Hospital


Presentation Title
Fertility options for women with gynaecological cancers

Speaker Bio
Dr Bambang MRCOG PhD has been at the Hewitt Centre for just under 10 years. She has a special interest in fertility preservation and Recurrent Pregnancy Loss. She also does a Paediatric Gynaecology clinic at Alder Hey Children’s Hospital NHS Trust.

She has a PhD in early pregnancy. She underwent core training in Birmingham and Manchester hospitals and then undertook subspecialty training in reproductive medicine and surgery at the Liverpool Women’s NHS Foundation Trust. She completed this in 2018 and was appointed there as a consultant in 2019.

She is lead for fertility preservation for children and young adults and is a founding member of the Northern Consortium for Fertility Preservation.

She has published in a range of peer reviewed journals and has also contributed to books. She is also on the steering committee for the ESHRE European Fellowship in Reproductive Medicine.

Paula Briggs

Paula Briggs

Consultant in Sexual and Reproductive Health, Liverpool Women's Hospital


Presentation Title
Menopause: how to support women with gynaecological cancers

Speaker Bio
Paula is a Consultant in Sexual and Reproductive Health based at Liverpool Women’s NHS Foundation Trust. She is Chair of the British Menopause Society.

Paula qualified from University of Glasgow in 1987 and trained as a GP before moving to Liverpool in 1993, working in General Practice and Sexual Health until 2012.

She is now devoted to the delivery of women’s health care, research and education. Her main interest is menopause management, with a particular interest in urogenital atrophy.

She has co-edited 3 books, (one second edition), co-written an undergraduate textbook in Obstetrics and Gynaecology, a revision guide for MFSRH and a book specifically for men about female hormones. She has also written a patient booklet on menopause (second edition). She co-authored a myth busting book on contraception for the lay public and is working on a similar menopause patient book with colleagues currently. She also has 2 new patient booklets, one co-authored on sexual and reproductive health after gynaecological cancer and the other on urogenital atrophy.


Friday 12th July

Alexander Barrett

Mr Alexander Barrett

MRI Physicist, Clatterbridge Cancer Centre


Presentation Title
Gynaecological MRI: Current limitations and future innovations

Speaker Bio
Alexander is a Clinical Scientist specializing in MRI & US Physics at the Clatterbridge Cancer Centre, and an honorary lecturer at the University of Liverpool. His role includes optimisation and implementation of new advanced acceleration technologies in MRI across Cheshire and Merseyside as well as advising on safety and quality assurance.

Over the past two years, he has worked closely with radiologists to improve gynaecological MRI scanning using the latest AI technologies and advanced MRI techniques to enhance both speed and image quality.

Alex Laios

Mr Alex Laios

Consultant Gynaecological Oncologist, St James’s University Hospital & Institute of Oncology, Leeds Teaching Hospitals Trust,


Presentation Title
AI and predictive scoring for ovarian cancer

Speaker Bio
Mr Laios obtained his Ph.D. from Trinity College Dublin, Ireland where his research focused on the molecular biology of ovarian cancer. He engaged in establishing integral components of ovarian cancer genomics at the University of Oxford. He completed his post-doctorate training alongside his clinical commitments by designing and coordinating the first in the UK pilot Clinical Trial in the detection of sentinel lymph nodes in gynaecological cancers by using of Near Infrared Imaging technology and Indocyanine Green dye (ICG).

Currently, his research focuses on the application of Machine Learning algorithms in improving the predictive and prognostic accuracy of advanced-stage ovarian cancer outcomes.


Tara Barwick

Prof Tara Barwick

Consultant in Radiology and Nuclear Medicine, Imperial College Healthcare NHS Trust


Presentation Title
The role of PETCT in gynaecological cancer

Speaker Bio
Prof Barwick is a dual accredited Consultant in Radiology and Nuclear Medicine at Imperial College Healthcare NHS Trust London and Professor of Practice (Cancer Imaging) at Imperial College London.

She completed Radiology training at Bart’s and The London followed by subspecialist Nuclear Medicine and PET training at Guy’s and St Thomas’ NHS Foundation Trust. Her main clinical and research interests are oncological PET/CT, particularly prostatic and gynaecological malignancies, lung cancer and lymphoma.

Although primarily clinically based, she is active in research with over 80 peer reviewed publications.


Friday 12th July

Ehsan Ghorani

Ehsan Ghorani

Consultant Medical Oncologist, Imperial College London


Presentation Title
New therapies for low grade and clear cell ovarian cancers

Speaker Bio
Dr Ghorani is a CRUK Clinician Scientist, leading the Cancer Immunology and Immunotherapy lab at Imperial College London, and a consultant medical oncologist within the Charing Cross Hospital Gestational Trophoblastic Disease unit. His work focusses on mechanisms of cancer immune evasion and immune regulation with a particular interest in gestational trophoblastic neoplasia (GTN) and lung cancer.

He is Chief Investigator of the phase II RESOLVE study of neoadjuvant pembrolizumab in GTN and Translational Lead on the UK phase III REFINE-Lung study.

Charlie Gourley

Charlie Gourley

Professor of Medical Oncology and Honorary Consultant in Medical Oncology, University of Edinburgh


Presentation Title
New therapies for low grade and clear cell ovarian cancers

Speaker Bio
Charlie graduated with Genetics and Medicine degrees from Glasgow University, UK, in 1991 and 1994, respectively. From 1998 to 2005, he trained in medical oncology at the Edinburgh Cancer Centre, UK, during which he was awarded a PhD in ovarian cancer genetics from the University of Edinburgh and an NHS Education for Scotland Clinician Scientist Award. He was appointed as Senior Lecturer in Medical Oncology at the University of Edinburgh in 2005, Reader in Medical Oncology in 2011 and Professor of Medical Oncology (Personal Chair) in 2012. He received a Scottish Senior Clinical Fellowship Award in 2010. He became Director of the Nicola Murray Centre for Ovarian Cancer Research in 2016, Clinical Director of the Cancer Research UK (CRUK) Edinburgh Centre in 2019 and Clinical Director of the Cancer Research UK Scotland Centre in 2022. He is a member of the CRUK Clinical Research Committee and the German Cancer Aid Scientific Review Committee.

Charlie’s clinical research focus is ovarian cancer clinical trials. He was UK Lead for the SOLO1 trial, which led to the first-line licence for olaparib in BRCA-mutant ovarian cancer, and for the GOG281/LOGS trial of trametinib, which is the first positive randomised controlled trial in low-grade serous ovarian cancer.

Charlie’s translational research focuses on genomic characterisation of ovarian cancer in order to facilitate the discovery of biomarkers of ovarian cancer drug sensitivity and resistance. His current priorities include whole-genome sequencing of ovarian cancer tumours from across Scotland in order to improve patient selection for novel therapies and exomic sequencing of low-grade serous ovarian cancers from patients recruited into the GOG281/LOGS study in order to improve patient selection for MEK inhibition. His research group have also recently reported a comprehensive genomic characterisation of endometrioid ovarian cancer.


Friday 12th July

Neil Ryan

Dr Neil Ryan

Subspecialty Trainee in Gynaecological Oncology, Royal Infirmary of Edinburgh


Presentation Title
Cancer genetics and Lynch screening

Speaker Bio
Neil is the RCOG Subspecialty Trainee in Gynaecology Oncology at the Royal Infirmary of Edinburgh and a CSO/NES Clinical Lecturer at the University of Edinburgh.

Prior to O&G training he completed basic training in Ear Nose and Throat Surgery. He was awarded a personal MRC fellowship to undertake a PhD at the University of Manchester (UoM) which he completed in 2020. His thesis was supervised by Professors Crosbie and Evans.

His PhD led to a change in NICE guidelines relating to the testing of womb cancer along with numerous publications, presentations, invited lectures and awards.

Neil’s work was recognised by a President’s Doctorial Scholarship and awarded the UoM’s highest postgraduate award: The President’s Medal. Neil was recently awarded the William Blair Bell Lecture by the Royal College of Obstetricians and Gynaecologists (RCOG). Furthermore, Neil won the Herbert Reiss Prize from the Royal Society of Medicine.

Neil has been invited to sit on several national and international committees including the RCOG’s Genetics Task Force, The British Gynaecological Cancers Society’s guideline subcommittee, The European Hereditary Cancer Group, Lynch Syndrome UK’s Clinical Advisory group and the Royal Society of Medicine’s Obstetrics and Gynaecological committee.

Neil is currently pursuing a career in academic gynaecology oncology and is seeking to explore ways to improve the care of women with gynaecological cancer by improving personalised treatments and identifying those at increased risk of cancer. He is currently applying for national grants to undertake this work.

Neil is an active member of the Army Reserves holding the rank of Major in the Royal Army Medical Corps.

Ranjit Manchanda

Prof Ranjit Manchanda

Professor of Gynaecological Oncology, Queen Mary University of London & Barts Health NHS Trust


Presentation Title
Ovarian cancer screening: have we given up?

Speaker Bio
Ranjit leads the Women’s Precision Prevention team at Barts Health NHS Trust, London.

He holds an Honorary Professorship at the Department of Health Services Research, London School of Hygiene & Tropical Medicine.

Ranjit’s main research interests are focused on Targeted Precision Prevention. This includes population-based genetic testing, mainstreaming genetic testing and precision medicine approaches for risk prediction, stratification, targeted ovarian cancer screening and targeted cancer prevention, along with health economic issues related to these areas of research. He leads a number of studies/trials in these areas.

He is a member of a number of advisory and oversight committees.

He is the Topic Advisor (Clinical Lead) for the NICE guideline on Ovarian cancer: identifying and managing familial and genetic risk; and Chair NCRI Gynaecological Cancer Early Diagnosis Working Group. He is an NHS Innovation Accelerator Alumnus and has served as the President of ENYGO.

Maggie Cruickshank

Prof Maggie Cruickshank

Emeritus Professor of Gynaecology, University of Aberdeen


Presentation Title
HPV vaccination and effect on gynaecological cancers

Speaker Bio
Maggie is a Consultant Gynaecologist in NHS Grampian, with special interest in precancer of lower genital tract and anus, and an Emeritus Professor at the University of Aberdeen.

She is President of the European Federation of Colposcopy and chair the Training and Education Committee of the International Federation of Colposcopy and Cervical Pathology.


Friday 12th July

Daniel Monnery

Daniel Monnery

Consultant in Palliative Care Medicine, Clatterbridge Cancer Centre


Presentation Title
Principles of palliative care in gynaecological cancers

Speaker Bio
Dan is a consultant in palliative medicine and clinical lead for palliative and supportive care at The Clatterbridge Cancer Centre in Liverpool.

He is the national lead for Enhanced Supportive Care (ESC) within the UK Association of Supportive Care in Cancer (UKASCC), having been the NHS England national clinical advisor from 2021-22.

His clinical work focusses on early symptom intervention through integration of supportive care services with a view to improving outcomes for patients from easier access to supportive care.


Friday 12th July

Ane Gerda Zahl Eriksson

Dr Ane Gerda Zahl Eriksson

Senior Consultant, Oslo University Hospital


Presentation Title
SHAPE Trial – an update

Speaker Bio
Associate Professor Ane Gerda Eriksson is a senior consultant at the Department of gynecologic cancer and head of the endometrial cancer and gynecologic sarcoma team at the Norwegian Radium Hospital, Oslo University Hospital.

Dr Eriksson received her Medical Degree from the Medical University of Warsaw in Poland and completed residency training at Oslo University Hospital in Norway. She then completed fellowship in Gynecologic Oncology at Memorial Sloan Kettering Cancer Centre, New York, in 2015, and has since returned to the department of Gynecologic Oncology at the Norwegian Radium Hospital where she provides surgical and medical treatment for women with gynecologic malignancies.

Her principal area of clinical practice is advanced minimal invasive surgery for gynecologic cancers and radical procedures for advanced ovarian cancer. She holds a special interest in surgical education. She is an invited international speaker and educator, and is the founder and chair of the Advanced course in cytoreductive surgery for ovarian cancer organized at Oslo University Hospital. Dr Eriksson also chairs the bi-annual Tropè meetings in our department and is an OncoAlert faculty.

Ane Gerda Eriksson defended her PhD on “Sentinel lymph nodes in endometrial carcinoma -Mapping, diagnostic accuracy and oncologic outcome” in 2018, and completed The Global Clinical Scholars Research Training Program at Harvard Medical School to further gain experience in design and implementation of clinical trials. Dr. Eriksson has a strong interest in clinical research. She takes part in ongoing collaborative trials at the Norwegian Radium Hospital and is a member of the Clinical Trials Unit of the Nordic Society of Gynecologic Oncology when she is the NSGO principal investigator/coordinator for the SENTICOL III trial. Dr. Eriksson has attracted competitive external funding from the Sister Institution Fund in collaboration with MD Andersen, and supervises master and PhD students at the University of Oslo, OSLOMET and NTNU. In her previous role as social media editor for the International Journal of Gynecologic Cancer she mentored numerous international editorial fellows. She is currently a mentor in the European Society of Gynecologic Oncology (ESGO) gender equity program.

Dr Eriksson holds a special interest in image-guided surgery as well as molecular markers in endometrial cancer. She is currently investigating the implementation of sentinel lymph node biopsy in the South Western health region in Norway and has recently initiated a study exploring outcomes after fertility preservation in women with early stage cervical cancer and dysplasia. Dr Eriksson is an active member of several national and international societies. She is currently a Council Member of ESGO.

David Cibula

Prof David Cibula

Professor of Gynaecological Oncology, 1st Faculty of Medicine, Charles University


Presentation Title
De-escalation of surgery in cervical cancer

Speaker Bio

  • Head, Department of Obstetrics and Gynecology, General University Hospital in Prague
  • Professor, First Faculty of Medicine, Charles University; Past-President, European Society of Gynaecologic Oncology (ESGO) (2017 – 2019)
  • Founder and Chair, Central and Eastern European Gynecologic Oncology Group (CEEGOG); Chair, ESGO working group on Clinical Practice Guidelines on Cervical Cancer (2016-2023)
  • Founder and Vice-Chair; Czech Society of Hospital Gynaecologists and Obstetricians; Chair, Czech Society of Gynaecologic Oncology

Conference Dinner - Thursday 11th July 2024

Liverpool Town Hall


Situated in the heart of the Commercial District, the historic  Liverpool Town Hall is a masterful example of Georgian architecture and will provide an awe-inspiring backdrop for the dinner.

Expect drinks, a 3 course dinner and entertainment from one of the finest tribute bands around!

Tickets are £60.00 and will be available to purchase during registration for the main conference, which will open in November 2023.

Registration Type Early rate (available until 10 May 2024) Late rate (from 11 May 2024) Onsite rate (from 10 July 2024)
Consultant (BGCS Member) £360.00 £395.00 £425.00
Consultant (Non-member) £420.00 £455.00 £500.00
Fellows/Trainees (BGCS Member) £250.00 £275.00 £300.00
Fellows/Trainees (Non-member) £285.00 £320.00 £350.00
Nurse/AHP (BGCS Member £150.00 £200.00 £220.00
Nurse/AHP (Non-member) £175.00 £235.00 £260.00
Student £185.00 £220.00 £245.00
Industry £450.00 £500.00 £550.00
Scientist/Non-Clinical £240.00 £265.00 £285.00
Retired Member £180.00 £180.00 £180.00
Charity Rate £200.00 £200.00 £200.00


Payment of Registration Fees
Full payment must be made by credit/debit card at the time of registering. Cards accepted are VISA, Visa Debit and MasterCard. Unfortunately we cannot accept American Express or Maestro.

Full payment must be received in full prior to the conference. If you register at the early registration rate, payment must be received in full by the early registration deadline. If payment is not received at this time, your registration rate will automatically be changed to late registration and the higher fee will be due.

On receipt of your registration form, a confirmation email and receipt will be sent to you by the conference organisers. If you have not received this within 5 working days of registering, please contact the conference organisers by emailing

Cancellation Terms
Notification of cancellation must be sent by email to, please ensure you receive an acknowledgment. Cancellations will incur an administration fee of £40.00. If you cancel your place after Monday 29 May 2024, the total conference fee will be charged and you will not receive any refund. Name changes however, will be permitted until 24 hours prior to the conference.

By submitting your registration, you agree to the terms of the cancellation policy.

Abstract Submission - Key Dates

Abstract Submission Opens Tuesday 14th November 2023
Abstract Submission Deadline Wednesday 20th March 2024
Notification to Authors Monday 29th April 2024
Early Registration Deadline Friday 10th May 2024


To submit an abstract, you need to log in to our Online Abstract Submission Site. Once you have created an account, you can log in multiple times to complete your submission(s). Please remember to take a note of your password.

Abstract Format

Your abstract needs to follow the BGCS Abstract Template. The word limit is 250 words and all abstracts must be written and presented in English. Please do not add any images or table; use only plain text and follow the headings in the document as a guide for your abstract structure. Once your abstract is complete, save the document and you will be asked to upload it during the submission process.

Abstract Type and Theme

You can choose to submit an abstract for consideration as a Short Oral Presentation, a Poster Presentation or a Surgical Video Presentation, under one of the following themes.

  • Clinical Oncology
  • Endometrial Cancer
  • Medical Oncology
  • Nursing
  • Ovarian Cancer
  • Palliative and Supportive Care
  • Rare Tumours
  • Screening and Prevention
  • Surgical Technique
  • Vulval Cancer

Submission Deadline

The deadline to submit an abstract for BGCS 2024 is 12:00 (GMT) on Wednesday 20th March 2024. You need to ensure you have completed the submission process before this date. Any submissions in the draft status will not be considered for review.

Read the full submission guidelines here.

Notification to Authors

Authors will be notified about the outcome of their submission(s) during the week commencing Monday 29 April 2024. The notification will be sent to the submitting author only.

Prizes and Bursaries

The deadline to submit an abstract for BGCS 2024 is 12:00 (GMT) on Wednesday 20th March 2024. You need to ensure you have completed the submission process before this date. Any submissions in the draft status will not be considered for review.

Notification to Authors

Authors will be notified about the outcome of their submission(s) during the week commencing Monday 29th April 2024. The notification will be sent to the submitting author only.

  • Venue - ACC Liverpool

    ACC Liverpool

    King’s Dock
    Port of Liverpool
    Kings Dock Street
    Liverpool L3 4FP

    Located on the banks of the River Mersey, in the heart of the city, ACC Liverpool is home to the only purpose built, interconnected Convention Centre, Arena and Exhibition Centre in Europe.

    The award winning residential venue offers an array of amenities within a 15 minute walk, including the Grade 1 listed Royal Albert Dock, home to Tate Liverpool, The Beatles Story and offering a diverse range of cafes and restaurants, Liverpool ONE shopping centre and the famous Mersey ferry terminal.

    ACC Liverpool’s central location means everything is within walking distance however, should you require public transport, the venue is very well served by circular bus routes, rail, underground and an extensive motorway network. The city’s main railway station (Lime Street) is just a 20 minute walk (or a 5 minute taxi ride) from ACC Liverpool.

  • Liverpool - The City

    Liverpool is an iconic and exciting city to visit. Walkable and compact – taking just 25 minutes to walk across the city – rich in heritage, culture and sport, Liverpool offers a unique opportunity to immerse yourself in a welcoming, vibrant, and diverse place.

    The heart of the city is wrapped around the world-famous Liverpool waterfront. The Royal Albert Dock has the largest collection of Grade I listed buildings in the UK.
    Royal Albert Dock

    Train stations, hotels, shopping centres, cafes, bars, restaurants and visitor attractions are all within walking distance of each other.

    Liverpool also boasts a wide range of cultural attractions alongside its rich maritime heritage and stunning architecture. The Royal Albert Dock is home to Tate Liverpool, The Maritime Museum and the International Slavery Museum which are all free of charge.

    Dazzle Ferry

    Liverpool’s status as UNESCO City of Music provides great opportunities for music lovers of all genres.  Whether it’s classical music at The Liverpool Philharmonic, The Beatles or the vibrant live music scene, there is something to suit all tastes.

  • Getting there

    By Air
    Liverpool is centrally located within the UK and has two international airports on its doorstep; Liverpool John Lennon Airport is just 20 minutes from central Liverpool whilst Manchester Airport is 45 minutes.

    John Lennon Airport

    Serving a combined 33 million passengers a year, Liverpool and Manchester airports are the gateways to the North of England. With an  ever-expanding network of  international destinations, alongside a host of European connections, it’s never been easier to get to Liverpool.

    By Rail
    Getting to Liverpool by train is quick and easy, with regular rail services from all over the UK taking you  straight to Liverpool Lime Street in the heart of the city.

    Lime Street Station

    The journey from London to Liverpool takes just over 2 hours with Avanti West Coast operating hourly direct services.

    London Midland Trains and First TransPennine Express also run routes into Liverpool from all major UK cities.

    Once in Liverpool, the extensive Merseyrail train network has four train stations serving the city centre, and excellent links to all parts of the city region.

    By Road
    Liverpool City Region is well-connected to the UK motorway network.

BGCS 2024 Accommodation Options

BGCS 2024 will be hosted at the ACC Liverpool, which is right on the iconic Liverpool waterfront and is well serviced in terms of accommodation.

Accommodation is not included in the registration rate but we are delighted to assist you book your accommodation by listing various hotels nearby the venue.

A few hotels have offered a special delegate discount rate, with booking links and codes included in the details listed below.

Please follow the booking instructions for each hotel to make your booking.

Please note the following before booking:

  • Rates apply to 9th-12th July 2024 (should delegates wish to book outside this date range, they will be offered Best Available Rates)
  • Rates are based on live availability and rooms will be allocated on a first come first served basis
  • Room rates include breakfast and VAT, unless otherwise stated

Pullman Hotel Liverpool  – View website
Kings Dock, Liverpool, L3 4FP

The 4* Pullman Hotel is located next to the ACC Liverpool and is connected to the venue by an enclosed walkway.

Situated on Liverpool’s iconic waterfront, just a five-minute walk from the vibrant Royal Albert Dock and walking distance to the city centre.

You can relax in stylish, elegant surroundings and enjoy the conveniences of this central hotel with beautiful rooms, all of which are bright, modern, and luxurious, all including rainfall showers, 55″ television with on demand movies, tea and coffee making facilities and slippers and robes.

Room Rates – Single Occupancy
Tuesday 9th July – £115
Wednesday 10th July – £175
Thursday 11th July – £175
Friday 12th July – £185

Double occupancy – £14 supplement per person per night on above rates.

Book before 14th May 2024 to take advantage of the above rates.

*Bookings will open by the end of November.

Leonardo Hotel Liverpool  – View website
31 Keel Wharf, Liverpool, L3 4FN

Located on the edge of the river Mersey and next door to the famous Royal Albert Dock, few Liverpool hotels can boast a better location. Decorated in an effortlessly cool, eclectic style, your stay will be as on-trend as the city itself.

Leonardo Hotel Liverpool is fully equipped for the occasion, with spacious, comfortable bedrooms, a trendy bar and restaurant with city views and an enviable location on Kings Waterfront, just 10 minutes’ walk from Liverpool Central train station and opposite the M&S Bank Arena.

Room Rates

  • Single Occupancy – £115 (rate on Friday 12th July – £145)
  • Double Occupancy – £125 (rate on Friday 12th July – £155)

Book online or call the Reservation team on 0870 4100 800 before 11th June 2024, and use the code LHBGCS0907240, take advantage of the above rates.

Staybridge Suite Liverpool View website
21 Keel Wharf, L3 4FN Liverpool

Staybridge Suites Liverpool offers comfortable fully-equipped studio and one-bedroom suites in the Royal Albert Docks area of Liverpool.

Explore Liverpool from this centrally located hotel, opposite the M&S Bank Arena and part of the iconic Royal Albert Docks. Enjoy all that the city has to offer during your stay including the famous Wheel of Liverpool, The Beatles Story museum, the Tate Liverpool and a great selection of bars and shopping right on our doorstep.

During your stay, workout in our 24/7 Fitness Centre, stock up on provisions from The Pantry.

Studio Apartments

  • Single Occupancy – from £160
  • Double Occupancy – £175

Book before 11th June 2024 take advantage of the above rates.

*Bookings will open by the end of November.

An opportunity for collaboration

Join us at the premiere scientific gynaecological cancer meeting of the year, at the BGCS Annual Scientific Meeting 2024.

We are bringing together experts from all over the UK and overseas, along with a wide range of delegates working in different aspects of the field; all waiting to engage with their peers and like-minded professionals.

Why support BGCS 2024?

Gain focused exposure for your brand and make a lasting impression on a highly targeted audience, through our sponsorship opportunities.

Our packages allow you to:

  • Promote your organisation’s work through a sponsored symposium
  • Align your brand with the Meeting, with advertising options on the mobile app and the digital programme
  • Enhance the visibility of your company through branding essential items, including lanyards and conference bags

Exhibit with us

BGCS 2024 also offers the opportunity to generate leads and connect with potential clients, partners and collaborators.

With a presence in our exhibition hall, you can:

  • Showcase technologies, innovations and solutions to a receptive audience
  • Share your latest research and findings
  • Explore networking opportunities; nurture existing relationships and form new ones that could translate to long-term business success

Get in touch

Packages and exhibition spaces are selling fast; secure your spot early and maximize your impact.

Contact us for further information and details on how to book at

Exhibition and Sponsorship

The BGCS wishes to thank and acknowledge our 2023 Annual Scientific Meeting sponsors:



















If you would like to receive a copy of the sponsorship and exhibition brochure, please email






For UK Healthcare Professionals Only

GSK Sponsored Symposia 

As one of our Platinum Sponsors, GSK will be offering delegates the opportunity to attend their Symposia, taking place in the Great Hall, on Friday 8th July.

There is no need to register in advance.

Early Morning Symposium * (breakfast will be provided)
09:00-09:30, Great Hall 

The GARNET trial – reshaping the advanced endometrial treatment landscape.

Welcome and introduction
Dr Susana Banerjee, Consultant Medical Oncologist, The Royal Marsden, London (Chair).

The GARNET trial at ASCO: clinical outcomes from 2 years of survival follow-up
Dr Susana Banerjee

Application of GARNET trial data in clinical practice
Dr John McGrane, Consultant Clinical Oncologist, Royal Cornwall Hospitals, Truro.

Moderated by Dr Susana Banerjee

Lunchtime Symposium **
13:10 -13:55, Great Hall

A patient-centric, multidisciplinary approach to decision-making for first-line maintenance therapy in advanced ovarian cancer.

Welcome and introduction
Dr Rowan Miller, Consultant Medical Oncologist, University College London and St Bartholomew’s Hospitals, London, Chair.

Overview of first-line maintenance therapy options in newly diagnosed advanced ovarian cancer
Dr Rowan Miller

Patient case study – Clinical assessment
Ms Lisa Young, Macmillan Lead Gynae Cancer CNS, University Hospital Southampton NHS Foundation Trust, Southampton

PRIME and PRIMA clinical data presentation
Dr Clare Green, Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust, Southampton

Patient case study – Patient-centric care
Ms Lisa Young

Multidisciplinary team discussion about patient management

Summary and close
Dr Rowan Miller

*This promotional symposium is funded and organised by GSK and will include information about the GSK-promoted product, JEMPERLI (dostarlimab) 

INDICATION: JEMPERLI (dostarlimab) is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) recurrent or advanced endometrial cancer (EC) that has progressed on or following prior treatment with a platinum-containing regimen.1

JEMPERLI Prescribing Information – Great Britain is available here.

JEMPERLI Prescribing Information – Northern Ireland is available here. 

1. JEMPERLI (dostarlimab) Summary of Product Characteristics. 

**This promotional symposium is funded and organised by GSK and will include information about the GSK product, Zejula (niraparib) 

INDICATION: Zejula (niraparib) is indicated as monotherapy for the maintenance treatment of adult patients with advanced epithelial (FIGO Stages III and IV) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. Zejula is indicated as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum-based chemotherapy.2 

Zejula Prescribing Information – Great Britain is available here.

Zejula Precribing Information – Northern Ireland is available here.

2. Zejula (niraparib) Summary of Product Characteristics. 

Adverse events should be reported. Reporting forms and information can be found at or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to GSK Limited on +44 (0) 800 221 441.

PM-GB-DST-WCNT-220005 | July 2022